Global trends in Clostridioides difficile infection–related mortality, 2001-2023: An observational study
Although CDI-related mortality has declined globally over the past decade, the disease remains a significant threat, especially in older populations. Ongoing global efforts are essential to further reduce CDI-related deaths.
Authors
- Yoshito Nishimura (ORCID: https://orcid.org/0000-0003-0224-7501)
- Hideharu Hagiya (ORCID: https://orcid.org/0000-0002-5086-1891)
- Yoshito Zamami (ORCID: https://orcid.org/0000-0002-7879-423X)
- Ko Harada (ORCID: https://orcid.org/0000-0002-3801-1472)
- Toshihiro Koyama (ORCID: https://orcid.org/0000-0002-7755-1754)
- Maki Yamamoto
- Tatsuaki Takeda (ORCID: https://orcid.org/0000-0002-9872-2559)
- Quynh Thi Vu (ORCID: https://orcid.org/0009-0000-8084-8164)
- Hanane OUDDOUD (ORCID: https://orcid.org/0009-0006-2535-4122)
- Keith Pardillada Belangoy (ORCID: https://orcid.org/0009-0001-4293-9708)
Institutions
- Mayo Clinic (US)
- Okayama University (JP)
- Hai phong University Of Medicine and Pharmacy (VN)
- Okayama University Hospital (JP)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1016/j.ijid.2025.108315
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Pfizer Health Research Foundation
- Japan Society for the Promotion of Science